Cellebrite DI Ltd.

NasdaqGS:CLBT Stock Report

Market Cap: US$4.1b

Cellebrite DI Valuation

Is CLBT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CLBT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CLBT ($20.18) is trading above our estimate of fair value ($19.71)

Significantly Below Fair Value: CLBT is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CLBT?

Key metric: As CLBT is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CLBT. This is calculated by dividing CLBT's market cap by their current revenue.
What is CLBT's PS Ratio?
PS Ratio11.4x
SalesUS$385.17m
Market CapUS$4.15b

Price to Sales Ratio vs Peers

How does CLBT's PS Ratio compare to its peers?

The above table shows the PS ratio for CLBT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average8.5x
BL BlackLine
6x8.2%US$3.7b
RIOT Riot Platforms
12.5x39.5%US$4.0b
AGYS Agilysys
14.3x19.6%US$3.5b
RNG RingCentral
1.3x6.9%US$3.2b
CLBT Cellebrite DI
11.4x14.0%US$4.1b

Price-To-Sales vs Peers: CLBT is expensive based on its Price-To-Sales Ratio (11.4x) compared to the peer average (8.5x).

Price to Sales Ratio vs Industry

How does CLBT's PS Ratio compare vs other companies in the US Software Industry?

80 CompaniesPrice / SalesEstimated GrowthMarket Cap
VYX NCR Voyix
0.6x-23.2%US$2.07b
PGY Pagaya Technologies
0.7x15.8%US$645.96m
XPER Xperi
0.8x1.8%US$387.78m
EGHT 8x8
0.5x1.1%US$371.08m
CLBT 11.4xIndustry Avg. 5.3xNo. of Companies80PS048121620+
80 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: CLBT is expensive based on its Price-To-Sales Ratio (11.4x) compared to the US Software industry average (5.1x).

Price to Sales Ratio vs Fair Ratio

What is CLBT's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CLBT PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio11.4x
Fair PS Ratio6.5x

Price-To-Sales vs Fair Ratio: CLBT is expensive based on its Price-To-Sales Ratio (11.4x) compared to the estimated Fair Price-To-Sales Ratio (6.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CLBT forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$20.18
US$22.43
+11.1%
5.3%US$24.00US$21.00n/a7
Nov ’25US$18.53
US$19.86
+7.2%
12.2%US$23.00US$17.00n/a7
Oct ’25US$16.52
US$19.14
+15.9%
13.2%US$23.00US$17.00n/a7
Sep ’25US$17.06
US$18.00
+5.5%
7.3%US$20.00US$17.00n/a7
Aug ’25US$13.39
US$14.36
+7.2%
6.6%US$16.00US$13.00n/a7
Jul ’25US$12.14
US$14.36
+18.3%
6.6%US$16.00US$13.00n/a7
Jun ’25US$10.65
US$14.36
+34.8%
6.6%US$16.00US$13.00n/a7
May ’25US$10.75
US$13.64
+26.9%
9.3%US$16.00US$12.00n/a7
Apr ’25US$11.01
US$13.75
+24.9%
9.8%US$16.00US$12.00n/a6
Mar ’25US$12.29
US$13.17
+7.1%
8.1%US$15.00US$12.00n/a6
Feb ’25US$9.21
US$10.17
+10.4%
8.8%US$12.00US$9.00n/a6
Jan ’25US$8.66
US$10.17
+17.4%
8.8%US$12.00US$9.00n/a6
Dec ’24US$8.42
US$10.00
+18.8%
11.5%US$12.00US$8.00n/a6
Nov ’24US$6.85
US$9.83
+43.6%
12.3%US$12.00US$8.00US$18.536
Oct ’24US$7.65
US$9.83
+28.5%
12.3%US$12.00US$8.00US$16.526
Sep ’24US$8.18
US$9.83
+20.2%
12.3%US$12.00US$8.00US$17.066
Aug ’24US$7.76
US$8.21
+5.8%
20.8%US$11.00US$6.50US$13.396
Jul ’24US$7.20
US$7.65
+6.3%
16.7%US$10.00US$6.50US$12.145
Jun ’24US$5.74
US$7.53
+31.2%
18.4%US$10.00US$6.15US$10.655
May ’24US$5.49
US$7.53
+37.2%
18.4%US$10.00US$6.15US$10.755
Apr ’24US$6.09
US$7.48
+22.8%
19.2%US$10.00US$5.90US$11.015
Mar ’24US$5.75
US$7.38
+28.3%
20.1%US$10.00US$5.90US$12.295
Feb ’24US$5.51
US$7.10
+28.9%
24.6%US$10.00US$5.00US$9.215
Jan ’24US$4.36
US$7.50
+72.0%
18.9%US$10.00US$6.00US$8.665
Dec ’23US$4.69
US$7.50
+59.9%
18.9%US$10.00US$6.00US$8.425
Nov ’23US$4.74
US$7.70
+62.4%
20.0%US$10.00US$6.00US$6.855

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Akamai Technologies

US$13.2b

Provides cloud computing, security, and content delivery services in the United States and internationally.

AKAM

US$91.08

7D

3.1%

1Y

-19.8%

Capgemini

€26.2b

Engages in the provision of consulting, digital transformation, technology, and engineering services primarily in North America, France, the United Kingdom, Ireland, the rest of Europe, the Asia-Pacific, and Latin America.

CAPM.F

€163.05

7D

-2.4%

1Y

-17.1%

Dye & Durham

CA$1.2b

Provides cloud-based software and technology solutions for law firms, financial service institutions, sole-practitioner law firms, and government organizations in Canada, Australia, South Africa, Ireland, and the United Kingdom.

DYND.F

CA$12.80

7D

6.1%

1Y

34.4%